mTOR aggravated CD4++ T cell pyroptosis by regulating the PPARγ-Nrf2 γ-Nrf2 pathway in sepsis

被引:1
|
作者
Zhao, Guoyu [1 ]
Xie, Yawen [1 ]
Lei, Xianli [1 ]
Guo, Ran [1 ]
Cui, Na [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, State Key Lab Complex Severe & Rare Dis, Dept Crit Care Med, Beijing 100730, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
mTOR; Pyroptosis; PPAR gamma; Nrf2; Sepsis; CD4+T cell; INDUCED IMMUNOSUPPRESSION; ACTIVATION;
D O I
10.1016/j.intimp.2024.112822
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a systemic inflammatory response syndrome caused by a dysregulated host response to infection. CD4+T + T cell reduction is crucial to sepsis-induced immunosuppression. Pyroptosis, a programmed necrosis, is concerned with lymphocytopenia. Peroxisome proliferator-activated receptor gamma (PPAR gamma) regulated by upstream mTOR, exerts anti-pyroptosis effects. To investigate the potential effects of mTOR-PPAR gamma on sepsis-induced CD4+T + T cell depletion and the underlying mechanisms, we observed mTOR activation and pyroptosis with PPAR gamma-Nrf suppression through cecal ligation and puncture (CLP) sepsis mouse model. Further mechanism research used genetically modified mice with T cell-specific knockout mTOR or Tuberous Sclerosis Complex1 (TSC1). It revealed that mTOR mediated CD4 + T cell pyroptosis in septic mice by negatively regulating the PPAR gamma-Nrf2 signaling pathway. Taken together, mTOR-PPAR gamma-Nrf2 signaling mediated the CD4+ + T cell pyroptosis in sepsis, contributing to CD4+T + T cell depletion and immunosuppression.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] PPAR Gamma and Nrf2 Activation on Adjustment of Hypertension Status
    Dovinova, Ima
    Gresova, Linda
    Kvandova, Miroslava
    Puzserova, Angelika
    Balis, Peter
    Majzunova, Miroslava
    Horakova, Lubica
    Barancik, Miroslav
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 159 : S89 - S90
  • [32] PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO
    Polvani, Simone
    Tarocchi, Mirko
    Galli, Andrea
    PPAR RESEARCH, 2012, 2012
  • [33] Altering β-Cell Proliferation In Vivo by Pharmacological Manipulation of the Nrf2 Pathway
    Katz, Liora S.
    Garcia-Ocana, Adolfo
    Scott, Donald
    DIABETES, 2018, 67
  • [34] Roles of Nrf2 in cell proliferation and differentiation
    Murakami, Shohei
    Motohashi, Hozumi
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 88 : 168 - 178
  • [35] CHML is an NRF2 target gene that regulates mTOR function
    Dodson, Matthew
    Dai, Wujing
    Anandhan, Annadurai
    Schmidlin, Cody J.
    Liu, Pengfei
    Wilson, Nathan C.
    Wei, Yongyi
    Kitamura, Naoya
    Galligan, James J.
    Ooi, Aikseng
    Chapman, Eli
    Zhang, Donna D.
    MOLECULAR ONCOLOGY, 2022, 16 (08) : 1714 - 1727
  • [36] Role of Nrf2 in cell senescence regulation
    Yuan, Huan
    Xu, Yan
    Luo, Yi
    Wang, Nuo-Xin
    Xiao, Jian-Hui
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (01) : 247 - 259
  • [37] Role of Nrf2 in cell senescence regulation
    Huan Yuan
    Yan Xu
    Yi Luo
    Nuo-Xin Wang
    Jian-Hui Xiao
    Molecular and Cellular Biochemistry, 2021, 476 : 247 - 259
  • [38] Nrf2 promotes neuronal cell differentiation
    Zhao, Fei
    Wu, Tongde
    Lau, Alexandria
    Jiang, Tao
    Huang, Zheping
    Wang, Xiao-Jun
    Chen, Weimin
    Wong, Pak Kin
    Zhang, Donna D.
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (06) : 867 - 879
  • [39] Nrf2 signaling pathway: Pivotal roles in inflammation
    Ahmed, Syed Minhaj Uddin
    Luo, Lin
    Namani, Akhileshwar
    Wang, Xiu Jun
    Tang, Xiuwen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (02): : 585 - 597
  • [40] Nrf2: new insight in cell apoptosis
    Bonay, M.
    Deramaudt, T. B.
    CELL DEATH & DISEASE, 2015, 6 : e1897 - e1897